Novan.

Biotech firm Novan filed for a Chapter 11 bankruptcy restructuring and agreed to sell most of its assets for $ 15 million. The company was formed in 2006 based on UNC Chapel Hill research, then went public in 2016. Its shares traded as high...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT